<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Metab Syndr Obes</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Metab Syndr Obes</journal-id><journal-id journal-id-type="publisher-id">DMSO</journal-id><journal-id journal-id-type="pmc">dmso</journal-id><journal-title-group><journal-title>Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy</journal-title></journal-title-group><issn pub-type="epub">1178-7007</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32273741</article-id><article-id pub-id-type="pmc">7102914</article-id><article-id pub-id-type="publisher-id">225968</article-id><article-id pub-id-type="doi">10.2147/DMSO.S225968</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title><italic>SLC30A8, CDKAL1, TCF7L2, KCNQ1</italic> and <italic>IGF2BP2</italic> are Associated with Type 2 Diabetes Mellitus in Iranian Patients</article-title><alt-title alt-title-type="running-authors">Vatankhah Yazdi et al</alt-title><alt-title alt-title-type="running-title">Vatankhah Yazdi et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vatankhah Yazdi</surname><given-names>Kazem</given-names></name><xref ref-type="aff" rid="AFF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Kalantar</surname><given-names>Seyed Mehdi</given-names></name><xref ref-type="corresp" rid="AN0001"/><xref ref-type="aff" rid="AFF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Houshmand</surname><given-names>Massoud</given-names></name><xref ref-type="aff" rid="AFF0002">2</xref><xref ref-type="aff" rid="AFF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Rahmanian</surname><given-names>Masoud</given-names></name><xref ref-type="aff" rid="AFF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Manaviat</surname><given-names>Masoud Reza</given-names></name><xref ref-type="aff" rid="AFF0005">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2406-6162</contrib-id><name><surname>Jahani</surname><given-names>Mohammad Reza</given-names></name><xref ref-type="aff" rid="AFF0006">6</xref></contrib><contrib contrib-type="author"><name><surname>Kamalidehghan</surname><given-names>Behnam</given-names></name><xref ref-type="aff" rid="AFF0002">2</xref><xref ref-type="aff" rid="AFF0007">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4434-561X</contrib-id><name><surname>Almasi-Hashiani</surname><given-names>Amir</given-names></name><xref ref-type="aff" rid="AFF0008">8</xref></contrib><aff id="AFF0001"><label>1</label><institution>Department of Genetic, Shahid Sadoughi University of Medical Sciences and Health Services</institution>, <addr-line>Yazd</addr-line>, <country>Iran</country></aff><aff id="AFF0002"><label>2</label><institution>Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB)</institution>, <addr-line>Tehran</addr-line>, <country>Iran</country></aff><aff id="AFF0003"><label>3</label><institution>Research Center, Knowledge University</institution>, <addr-line>Erbil</addr-line>, <addr-line>Kurdistan Region</addr-line>, <country>Iraq</country></aff><aff id="AFF0004"><label>4</label><institution>Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences and Health Services</institution>, <addr-line>Yazd</addr-line>, <country>Iran</country></aff><aff id="AFF0005"><label>5</label><institution>Department of Ophthalmology, Shahid Sadoughi University of Medical Sciences and Health Services</institution>, <addr-line>Yazd</addr-line>, <country>Iran</country></aff><aff id="AFF0006"><label>6</label><institution>Taban Health Care and Diabetes Clinic Lab</institution>, <addr-line>Tehran</addr-line>, <country>Iran</country></aff><aff id="AFF0007"><label>7</label><institution>Medical Genetics Department, Jiroft University of Medical Sciences and Health Services</institution>, <addr-line>Jiroft</addr-line>, <country>Iran</country></aff><aff id="AFF0008"><label>8</label><institution>Department of Epidemiology, School of Health, Arak University of Medical Sciences</institution>, <addr-line>Arak</addr-line>, <country>Iran</country></aff></contrib-group><author-notes><corresp id="AN0001">Correspondence: Seyed Mehdi Kalantar <institution>Reproductive &#x00026; Genetic Unit, Abortion Research Centre Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences and Health Services</institution>, <addr-line>Bau Ali Ave. Safaeyeh</addr-line>, <addr-line>Yazd</addr-line>, <country>Iran</country><phone>Tel +9838247086</phone><addr-line>Fax +9838247087</addr-line> Email kalantarsm@ystp.ac.ir</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>3</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>13</volume><fpage>897</fpage><lpage>906</lpage><history><date date-type="received"><day>04</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>18</day><month>2</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Vatankhah Yazdi et al.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Vatankhah Yazdi et al.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec id="S2001"><title>Background</title><p>Type 2 diabetes mellitus (T2DM) is a serious public health issue with significantly increasing rates across the world. The genome-wide association studies (GWAS) have previously manifested involved genes that remarkably enhance the risk of T2DM. In this study, the association of common variants with T2DM risk has been identified among Iranian population from Tehran province of Iran.</p></sec><sec id="S2002"><title>Methods</title><p>Here, the association of refSNPs with T2DM risk was examined on peripheral blood samples of 268 individuals including control group and patients with T2DM using the tetra amplification refractory mutation system (ARMS) methods and direct genomic DNA sequencing.</p></sec><sec id="S2003"><title>Results</title><p>Our study demonstrated that <italic>SLC30A8</italic> rs13266634 (T/C), <italic>CDKAL1</italic> rs10946398 (A/C), <italic>TCF7L2</italic> rs7903146 (C/T), <italic>KCNQ1</italic> rs2237892 (T/C), and <italic>IGF2BP2</italic> rs1470579 (A/C) polymorphisms are significantly associated with type 2 diabetes, but no significant association was identified for FTO rs8050136 and MTNR1B rs10830963 polymorphisms.</p></sec><sec id="S2004"><title>Conclusion</title><p>The prediction of refSNPs is remarkably needed for pharmacogenetics and pharmacogenomic approaches, in which the information would be useful for clinicians to optimize therapeutic strategies and adverse drug reactions in patients with T2DM.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>type 2 diabetes mellitus</kwd><kwd>T2DM</kwd><kwd>Iranian populations</kwd><kwd>the tetra amplification refractory mutation system</kwd><kwd>ARMS</kwd><kwd>the genome-wide association studies</kwd><kwd>GWAS</kwd></kwd-group><counts><fig-count count="2"/><table-count count="4"/><ref-count count="55"/><page-count count="10"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001"><title>Introduction</title><p>Type 2 diabetes mellitus (T2DM) is a multifactorial and complex metabolic disorder, characterized by chronic hyperglycemia due to impairment in insulin secretion and sensitivity.<xref rid="CIT0001" ref-type="bibr">1</xref> The frequency of T2DM is enhancing gradually due to environmental factors and interplay of different variation in multiple genes.<xref rid="CIT0002" ref-type="bibr">2</xref> The World Human Organization (WHO) estimated that the total number of individuals with T2DM will reach to 366 million throughout the world by 2030.<xref rid="CIT0003" ref-type="bibr">3</xref> The hallmark factors, influencing the prevalence of diabetes, include age, gender, ethnicity, lifestyle, and obesity,<xref rid="CIT0004" ref-type="bibr">4</xref> in which the prevalence of T2DM in Iranian population is approximately 7.7%.<xref rid="CIT0005" ref-type="bibr">5</xref> There are several important genetic factors in T2DM including high incidence of diabetes among monozygotic twins compare to dizygotic twins, familial history, ethnicity and migration studies.<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref></p><p>IGF2BP2 is extremely expressed in pancreatic islets and binds to IGF-2 (insulin-like growth factor 2) that plays remarkable roles in localization, stability and translation of RNA.<xref rid="CIT0008" ref-type="bibr">8</xref>&#x02013;<xref rid="CIT0010" ref-type="bibr">10</xref> KCNQ1 (potassium voltage-gated channel KQT-like subfamily, member 1) gene is expressed in pancreatic islets<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0012" ref-type="bibr">12</xref> and plays a central role for repolarization of the cardiac action potential and transportation of water and salt in epithelial tissues.<xref rid="CIT0013" ref-type="bibr">13</xref> Mutations in KCNQ1 gene are involved in deafness and long QT syndrome.<xref rid="CIT0014" ref-type="bibr">14</xref> Blockade of the channel with KCNQ1 inhibitors 293B resulting in insulin secretion,<xref rid="CIT0011" ref-type="bibr">11</xref> indicating that KCNQ1 channels may play functionally significant roles in regulation of insulin secretion. Previous studies demonstrated that TCF7L2 is an important regulator of insulin production and is also expressed in pancreatic islets.<xref rid="CIT0015" ref-type="bibr">15</xref> TCF7L2 plays a key role in expression and subsequent conversion of proinsulin into mature insulin through various TCF7L2-target genes and downstream regulatory signaling pathways.<xref rid="CIT0015" ref-type="bibr">15</xref> Additionally, TCF7L2 may also affect the insulin clearance and insulin sensitivity.<xref rid="CIT0015" ref-type="bibr">15</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref></p><p>The FTO rs8050136 polymorphism is associated with high risk of T2D.<xref rid="CIT0017" ref-type="bibr">17</xref>&#x02013;<xref rid="CIT0023" ref-type="bibr">23</xref> The FTO is a 2-oxoglutarate (2-OG) Fe(II) dependent demethylase. Previous studies demonstrated a potential role of FTO in nucleic acid repair.<xref rid="CIT0024" ref-type="bibr">24</xref> According to the previous studies, the exact molecular signaling pathways of FTO involved in human adiposity, cancer, metabolic disorders, obesity and T2D remain largely unknown.<xref rid="CIT0018" ref-type="bibr">18</xref>,<xref rid="CIT0025" ref-type="bibr">25</xref>,<xref rid="CIT0026" ref-type="bibr">26</xref> The MTNR1B is a new susceptibility gene involved in the regulation of glucose homeostasis and T2DM, encoding the melatonin receptor MT2, which is expressed in different tissues including pancreatic islets.<xref rid="CIT0027" ref-type="bibr">27</xref>&#x02013;<xref rid="CIT0030" ref-type="bibr">30</xref> The rs13266634 (C/T) in the SLC30A8 gene is associated with increasing risk of T2D, encoding zinc transporter 8, which is primarily expressed in pancreatic &#x003b2;-cells. Additionally, the major C-allele of rs13266634 is associated with a lower early insulin response to glucose and a high risk of T2D.<xref rid="CIT0031" ref-type="bibr">31</xref>,<xref rid="CIT0032" ref-type="bibr">32</xref> Due to the&#x000a0;limited number of controlled trials, there is to date no overall strong evidence supporting the theory&#x000a0;that zinc supplementation may lower the risk of T2D in humans.<xref rid="CIT0033" ref-type="bibr">33</xref> Previous studies demonstrated an interaction between plasma zinc levels and rs13266634 on T2D risk.<xref rid="CIT0034" ref-type="bibr">34</xref> Cyclin-dependent kinase 5 regulatory subunit-associated protein 1-like (CDKAL1) gene, located in 6p22.3, is associated with T2DM.<xref rid="CIT0035" ref-type="bibr">35</xref>
<italic>CDKAL1</italic> gene encodes tRNA decoration enzyme, namely methyl transfer enzyme which is involved in 2-methylthio-N6-threonylcarbamoyladenosine synthesis of the 37<sup>th</sup> base of tRNA Lys(UUU).<xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0037" ref-type="bibr">37</xref></p><p>Zinc is an essential element for insulin secretion and storage.<xref rid="CIT0038" ref-type="bibr">38</xref>&#x02013;<xref rid="CIT0040" ref-type="bibr">40</xref> Pancreatic beta cells contain&#x000a0;the highest level of Zinc compared to other cells in the&#x000a0;human body.<xref rid="CIT0041" ref-type="bibr">41</xref> The genome-wide association studies (GWAS) have extended the progress and distribution of different genetic components in type 2 diabetes.<xref rid="CIT0009" ref-type="bibr">9</xref> Today, there are at least 20 loci that are associated with T2DM risk, in which the SLC30A8 (rs13266634), CDKN2A/2B (rs10811661), HHEX (rs1111875) and TCF7L2 (rs7903146) play important roles in the risk of T2DM in European Caucasians.<xref rid="CIT0009" ref-type="bibr">9</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref>,<xref rid="CIT0042" ref-type="bibr">42</xref>,<xref rid="CIT0043" ref-type="bibr">43</xref> In this study, the association of different refSNPs with T2DM was investigated for the&#x000a0;prediction of T2DM risk among the&#x000a0;Iranian population.</p></sec><sec id="S0002"><title>Materials and Methods</title><sec id="S0002-S2001"><title>Specimen Collection and Ethical Statement</title><p>In this study, 268 peripheral blood samples, including 106 healthy and unrelated donors and 162 patients with T2DM, were obtained from Tehran Taban Health Care and Diabetes Clinic (TTHCDC) and Aramesh Genetic and Pathobiology Lab from Tehran. The whole peripheral blood samples collected in tubes containing ethylenediamine tetraacetic acid (EDTA) in a final volume of 2 mL. The written informed consent for participating in the study and allowing the&#x000a0;publishing of&#x000a0;information for genetic analysis were obtained from individuals. Approval to conduct this study was granted by the medical ethics committee of Shahid Sadoughi University of Medical Sciences and Health Services (approval number: IR.SSU.MEDICINE.REC.1395.90) in accordance with the Declaration of Helsinki. The inclusion criteria were patients older than 40 years who had&#x000a0;lived with type 2 diabetes for&#x000a0;more than 10 years. The&#x000a0;exclusion Criteria were: having chronic diseases such as heart failure, chronic kidney disease, chronic lung disease, diabetic foot or limb amputation, and moderate to severe retinopathy. The&#x000a0;exclusion criteria in the&#x000a0;control group were chronic disease or fasting blood sugar&#x0003e;100 mg/dl.</p></sec><sec id="S0002-S2002"><title>DNA Extraction Protocol</title><p>The DNA from whole peripheral blood samples was extracted using PrimePrep Genomic DNA extraction kit (GeNet Bio). The quantity and quality of extracted DNA was measured using Nanodrop, and then run on a 1% agarose gel electrophoresis.</p></sec><sec id="S0002-S2003"><title>Primer Design</title><p>The forward and reverse primers for identification of genes were designed using the&#x000a0;online Primer 1 program, available from <underline><ext-link ext-link-type="uri" xlink:href="http://primer1.soton.ac.uk/public">http://primer1.soton.ac.uk/public</ext-link></underline> html/primer1.html, developed by Ye and colleagues in 2001. The details of primers were checked using BLAST through <underline><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/tools/primer-blast/">https://www.ncbi.nlm.nih.gov/tools/primer-blast/</ext-link></underline>.</p><p>The two special set primers were designed by using <underline>the</underline>&#x000a0;primer1 program (<underline><ext-link ext-link-type="uri" xlink:href="http://primer1.soton.ac.uk/public_html/primer1.html">http://primer1.soton.ac.uk/public_html/primer1.html</ext-link></underline>) developed by Ye et al (2001). The specificity of primers and their melting temperatures were checked using BLAST (<underline><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih">http://www.ncbi.nlm.nih</ext-link></underline>). The details of the&#x000a0;primers are summarized in <xref rid="T0001" ref-type="table">Table 1</xref>.<table-wrap id="T0001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Represents List of Forward and Reverse Primers (Inner and Outer) Applied for Detection of SNPs</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">SNP ID</th><th colspan="2" rowspan="1">Forward and Reverse Primer Sequences (Outer &#x00026; Inner)</th><th rowspan="1" colspan="1">Primer Tm (C&#x000b0;)</th><th colspan="2" rowspan="1">Product Size(bp)</th></tr></thead><tbody><tr><td rowspan="4" colspan="1">1470579</td><td rowspan="1" colspan="1">FO</td><td rowspan="1" colspan="1">5&#x002b9;-ACA GAA ACA CAA TAA GAT CAT CAC AT-3&#x02019;</td><td rowspan="1" colspan="1">57.43</td><td rowspan="1" colspan="1">FO-RO</td><td rowspan="1" colspan="1">391</td></tr><tr><td rowspan="1" colspan="1">RO</td><td rowspan="1" colspan="1">5&#x002b9;-AAA TTT TTT ATG GAC ACT GAA GGT C-3&#x02019;</td><td rowspan="1" colspan="1">56.51</td><td rowspan="1" colspan="1">FO-RI</td><td rowspan="1" colspan="1">205</td></tr><tr><td rowspan="1" colspan="1">FI</td><td rowspan="1" colspan="1">5&#x002b9;-ATC ATT AGA TAA GAT CCA TAC GAG CTA-3&#x02019;</td><td rowspan="1" colspan="1">57.37</td><td rowspan="1" colspan="1">FI-RO</td><td rowspan="1" colspan="1">233</td></tr><tr><td rowspan="1" colspan="1">RI</td><td rowspan="1" colspan="1">5&#x002b9;-CTT TTC TTG ATA GGC AGG GTG-3&#x02019;</td><td rowspan="1" colspan="1">56.59</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="4" colspan="1">2237892</td><td rowspan="1" colspan="1">FO</td><td rowspan="1" colspan="1">5&#x002b9;-CTG TGG GTA CAC AGC TTC CCT-3&#x02019;</td><td rowspan="1" colspan="1">61.72</td><td rowspan="1" colspan="1">FO-RO</td><td rowspan="1" colspan="1">467</td></tr><tr><td rowspan="1" colspan="1">RO</td><td rowspan="1" colspan="1">5&#x002b9;-CCT GGG TCA TCA GAC TAG GGT AG-3&#x02019;</td><td rowspan="1" colspan="1">61.01</td><td rowspan="1" colspan="1">FO-RI</td><td rowspan="1" colspan="1">267</td></tr><tr><td rowspan="1" colspan="1">FI</td><td rowspan="1" colspan="1">5&#x002b9;-GTC ACA GGA CTT TGC CAA CC-3&#x02019;</td><td rowspan="1" colspan="1">59.33</td><td rowspan="1" colspan="1">FI-RO</td><td rowspan="1" colspan="1">239</td></tr><tr><td rowspan="1" colspan="1">RI</td><td rowspan="1" colspan="1">5&#x002b9;-TTT CTA GGC CCC TCA CCA CA-3&#x02019;</td><td rowspan="1" colspan="1">60.47</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="4" colspan="1">7903146</td><td rowspan="1" colspan="1">FO</td><td rowspan="1" colspan="1">5&#x002b9;-TTT TTC ACA TGT GAA GAC ATA CAC-3&#x02019;</td><td rowspan="1" colspan="1">56.15</td><td rowspan="1" colspan="1">FO-RO</td><td rowspan="1" colspan="1">429</td></tr><tr><td rowspan="1" colspan="1">RO</td><td rowspan="1" colspan="1">5&#x002b9;-TTT ATA GCG AAG AGA TGA AAT GTA G-3&#x02019;</td><td rowspan="1" colspan="1">55.10</td><td rowspan="1" colspan="1">FO-RI</td><td rowspan="1" colspan="1">269</td></tr><tr><td rowspan="1" colspan="1">FI</td><td rowspan="1" colspan="1">5&#x002b9;-ATT AGA GAG CTA AGC ACT TTT TAG AGA T-3&#x02019;</td><td rowspan="1" colspan="1">58.59</td><td rowspan="1" colspan="1">FI-RO</td><td rowspan="1" colspan="1">212</td></tr><tr><td rowspan="1" colspan="1">RI</td><td rowspan="1" colspan="1">5&#x002b9;-CTC ATA CGG CAA TTA AAT TAT AGA G-3&#x02019;</td><td rowspan="1" colspan="1">54.04</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="4" colspan="1">8050136</td><td rowspan="1" colspan="1">FO</td><td rowspan="1" colspan="1">5&#x002b9;-CCA TAC CAA CCA AGG TCC T-3&#x02019;</td><td rowspan="1" colspan="1">56.29</td><td rowspan="1" colspan="1">FO-RO</td><td rowspan="1" colspan="1">388</td></tr><tr><td rowspan="1" colspan="1">RO</td><td rowspan="1" colspan="1">5&#x002b9;-CAC ACC AAG ATG GTC ATG TC-3&#x02019;</td><td rowspan="1" colspan="1">56.43</td><td rowspan="1" colspan="1">FO-RI</td><td rowspan="1" colspan="1">237</td></tr><tr><td rowspan="1" colspan="1">FI</td><td rowspan="1" colspan="1">5&#x002b9;-GTT GCC CAC TGT GGC AGT A-3&#x02019;</td><td rowspan="1" colspan="1">60.23</td><td rowspan="1" colspan="1">FI-RO</td><td rowspan="1" colspan="1">189</td></tr><tr><td rowspan="1" colspan="1">RI</td><td rowspan="1" colspan="1">5&#x002b9;-AAC CAC AGG CTC AGA TAC TG-3&#x02019;</td><td rowspan="1" colspan="1">56.93</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="4" colspan="1">10830963</td><td rowspan="1" colspan="1">FO</td><td rowspan="1" colspan="1">5&#x002b9;-GGT TAA AGA GGC TGT CTG GGA GG-3&#x02019;</td><td rowspan="1" colspan="1">62.51</td><td rowspan="1" colspan="1">FO-RO</td><td rowspan="1" colspan="1">421</td></tr><tr><td rowspan="1" colspan="1">RO</td><td rowspan="1" colspan="1">5&#x002b9;-AGC CTT TGT TCA GAA CCA TGC TG-3&#x02019;</td><td rowspan="1" colspan="1">61.87</td><td rowspan="1" colspan="1">FO-RI</td><td rowspan="1" colspan="1">254</td></tr><tr><td rowspan="1" colspan="1">FI</td><td rowspan="1" colspan="1">5&#x002b9;-AGT GAT GCT AAG AAT TCA CAC CAT GTG-3&#x02019;</td><td rowspan="1" colspan="1">61.97</td><td rowspan="1" colspan="1">FI-RO</td><td rowspan="1" colspan="1">216</td></tr><tr><td rowspan="1" colspan="1">RI</td><td rowspan="1" colspan="1">5&#x002b9;-GGC AGT TAC TGG TTC TGG ATT GG-3&#x02019;</td><td rowspan="1" colspan="1">61.43</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="4" colspan="1">10946398</td><td rowspan="1" colspan="1">FO</td><td rowspan="1" colspan="1">5&#x002b9;-CAG GAT CTT GTG CTC CTC AC-3&#x02019;</td><td rowspan="1" colspan="1">57.98</td><td rowspan="1" colspan="1">FO-RO</td><td rowspan="1" colspan="1">424</td></tr><tr><td rowspan="1" colspan="1">RO</td><td rowspan="1" colspan="1">5&#x002b9;-CCA ACA GCA AGC AGT TGA TT-3&#x02019;</td><td rowspan="1" colspan="1">57.19</td><td rowspan="1" colspan="1">FO-RI</td><td rowspan="1" colspan="1">255</td></tr><tr><td rowspan="1" colspan="1">FI</td><td rowspan="1" colspan="1">5&#x002b9;-GGA AAA GGG TTT AGT ATC GCT C-3&#x02019;</td><td rowspan="1" colspan="1">55.67</td><td rowspan="1" colspan="1">FI-RO</td><td rowspan="1" colspan="1">214</td></tr><tr><td rowspan="1" colspan="1">RI</td><td rowspan="1" colspan="1">5&#x002b9;-GAT GAC TTG ATG CAA TGA CAG TAT-3&#x02019;</td><td rowspan="1" colspan="1">57.38</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="4" colspan="1">13266634</td><td rowspan="1" colspan="1">FO</td><td rowspan="1" colspan="1">5&#x002b9;-CTG CTG ATA GCA TTT GGG ACA GG-3&#x02019;</td><td rowspan="1" colspan="1">61.55</td><td rowspan="1" colspan="1">FO-RO</td><td rowspan="1" colspan="1">826</td></tr><tr><td rowspan="1" colspan="1">RO</td><td rowspan="1" colspan="1">5&#x002b9;-CCA ATT GAT TGA TGG ATC TCA GTG C-3&#x02019;</td><td rowspan="1" colspan="1">60.51</td><td rowspan="1" colspan="1">FO-RI</td><td rowspan="1" colspan="1">520</td></tr><tr><td rowspan="1" colspan="1">FI</td><td rowspan="1" colspan="1">5&#x002b9;-GCT TCT TTA TCA ACA GCA GCC AGC T-3&#x02019;</td><td rowspan="1" colspan="1">64.04</td><td rowspan="1" colspan="1">FI-RO</td><td rowspan="1" colspan="1">350</td></tr><tr><td rowspan="1" colspan="1">RI</td><td rowspan="1" colspan="1">5&#x002b9;-CGA ACC ACT TGG CTG TCC CG-3&#x002b9;</td><td rowspan="1" colspan="1">63.66</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap>
</p></sec><sec id="S0002-S2004"><title>Procedure of Tetra Primer ARMS-PCR</title><p>Essential keys for optimization of tetra ARMS are ration determination of outer and inner primers and annealing temperature. The unspecific bands were solved using gradient PCR system and optimization of outer and inner primer concentrations. The PCR reaction was performed in a final volume of 25 ul containing 1 &#x003bc;L Mg, 2.5 &#x003bc;L Buffer, 0.5 &#x003bc;L dNTP, 0.2 &#x003bc;L Taq polymerase, 1&#x003bc;L forward outer primer, 1 &#x003bc;L reverse outer primer, 2 &#x003bc;L forward inner primer, 2 reverse inner primer,1 &#x003bc;L DNA and 13.8 &#x003bc;L H2O. The DNA amplification was carried out using ARMS PCR for SNPs. The details of PCR reaction were as follows: 95&#x000b0;C for 5 min for cycle preparation,&#x000a0;30 cycles of denaturation at (95&#x000b0;C for 30 sec, annealing for 30 sec with different temperatures), polymerization at 72&#x000b0;C for 30 sec, and final extension at 72&#x000b0;C for 5 min with 1 cycle. The amplified fragment was confirmed and analyzed on 1.5% agarose gel (<xref rid="F0001" ref-type="fig">Figure 1</xref>).<fig id="F0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p><italic>ARMS-PCR</italic> analysis of the (<bold>A</bold>) rs2237892 C &#x0003e; T, (<bold>B</bold>) rs1470579 C &#x0003e; A, (<bold>C</bold>) rs10946398 C &#x0003e; A, (<bold>D</bold>) rs8050136 A&#x0003e;C, (<bold>E</bold>) rs10830963 C &#x0003e; G, (<bold>F</bold>) rs13266634 C &#x0003e; T and (<bold>G</bold>) rs7903146 T &#x0003e; C on 1.5% agarose gel. Note: Lanes 1, 2, 3 and 4 represent fo-ro/fo-ri/fi-ro, fo-ro/fo-ri, fo-ro/fi-ro and DNA molecular marker, respectively.</p></caption><graphic content-type="print-only" xlink:href="DMSO-13-897-g0001"/></fig></p></sec><sec id="S0002-S2005"><title>Single Nucleotide Polymorphisms (SNP) Identification</title><p>In this study, the SNPs were sequenced and the results were then identified using the&#x000a0;National Center for Biotechnology Information (NCBI) database, available at <underline><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP">http://www.ncbi.nlm.nih.gov/SNP</ext-link></underline>.</p></sec><sec id="S0002-S2006"><title>Sequencing Analysis</title><p>The double-stranded DNA of PCR products was examined using an automated ABI sequencing machine (ABI 3130 Genetic Analyzer, Baghiyatallah Hospital, Tehran-Iran). The DNA fragments were confirmed for any nucleotide variation and were then analyzed using Finch TV software (<underline><ext-link ext-link-type="uri" xlink:href="http://www.geospiza.com/finchtv/">http://www.geospiza.com/finchtv/</ext-link></underline>; PerkinElmer Inc., Waltham, MA, USA) (<xref rid="F0002" ref-type="fig">Figure 2</xref>).<fig id="F0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p>PCR-sequencing of (<bold>A</bold>) rs2237892 C &#x0003e; T, (<bold>B</bold>) rs1470579 C &#x0003e; A, (<bold>C</bold>) rs10946398 C &#x0003e; A, (<bold>D</bold>) rs8050136 A&#x0003e;C, (<bold>E</bold>) rs10830963 C &#x0003e; G, (<bold>F</bold>) rs13266634 C &#x0003e; T and (<bold>G</bold>) rs7903146 T &#x0003e; C. The highlighted blue area marks the polymorphisms.</p></caption><graphic content-type="print-only" xlink:href="DMSO-13-897-g0002"/></fig></p></sec><sec id="S0002-S2007"><title>Statistical Analysis</title><p>The odd ratios (OR) and 95% confidence intervals (CI) are used to determine the significant relationship of SNPs with T2DM. The Chi-square or Fisher exact test is used to analyze the results using STATA (V8) software. The <italic>p</italic>-values&#x0003c;0.05 is regarded as statistically significant.</p></sec></sec><sec id="S0003"><title>Results</title><p>The clinical and biomedical characteristic of patients with T2DM were compared with control groups and the results are summarized in <xref rid="T0002" ref-type="table">Table 2</xref>. This study demonstrated that there is a significant correlation (p&#x0003c;0.05) between T2DM patients and control groups with certain clinical parameters, including BMI, SBP, DBP, LDL, HDL, TG, 2hpp, FBS and HbA1c.<table-wrap id="T0002" orientation="portrait" position="float"><label>Table 2</label><caption><p>The Clinical and Biomedical Characteristics of Individuals in This Study</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Clinical Parameters</th><th rowspan="1" colspan="1">Controls (n=106)</th><th rowspan="1" colspan="1">T2DM Subjects (n=162)</th><th rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">65.5&#x000b1;7.3</td><td rowspan="1" colspan="1">65&#x000b1;7.5</td><td rowspan="1" colspan="1">0.64</td></tr><tr><td rowspan="1" colspan="1">BMI (Body Mass Index)</td><td rowspan="1" colspan="1">23.07&#x000b1;1.03</td><td rowspan="1" colspan="1">24.00&#x000b1;1.23</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td rowspan="1" colspan="1">SBP (Systolic Blood Pressure)</td><td rowspan="1" colspan="1">120.36&#x000b1;4.23</td><td rowspan="1" colspan="1">130.03&#x000b1;7.43</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td rowspan="1" colspan="1">DBP (Diastolic Blood Pressure)</td><td rowspan="1" colspan="1">84.89&#x000b1;3.01</td><td rowspan="1" colspan="1">88.75&#x000b1;4.59</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td rowspan="1" colspan="1">LDL (Low-Density Lipoprotein)</td><td rowspan="1" colspan="1">110.97&#x000b1;13.00</td><td rowspan="1" colspan="1">129.83&#x000b1;9.06</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td rowspan="1" colspan="1">HDL (High-Density Lipoprotein)</td><td rowspan="1" colspan="1">46.07&#x000b1;4.16</td><td rowspan="1" colspan="1">44.28&#x000b1;4.29</td><td rowspan="1" colspan="1">0.002*</td></tr><tr><td rowspan="1" colspan="1">TG (Triglyceride)</td><td rowspan="1" colspan="1">118.64&#x000b1;12.11</td><td rowspan="1" colspan="1">176.69&#x000b1;11.59</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td rowspan="1" colspan="1">2hpp (Two-Hour Postprandial Glucose)</td><td rowspan="1" colspan="1">121.56&#x000b1;3.60</td><td rowspan="1" colspan="1">235.35&#x000b1;12.97</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td rowspan="1" colspan="1">FBS (Fasting Blood Sugar)</td><td rowspan="1" colspan="1">87.32&#x000b1;4.35</td><td rowspan="1" colspan="1">165.20&#x000b1;22.51</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td rowspan="1" colspan="1">HbA1c (Glycated hemoglobin)</td><td rowspan="1" colspan="1">5.40&#x000b1;0.16</td><td rowspan="1" colspan="1">8.34&#x000b1;0.49</td><td rowspan="1" colspan="1">&#x0003c;0.001*</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Notes:</bold> Data are mean&#x000b1;S.D values; *Statistically significant.</p></fn><fn><p><bold>Abbreviations:</bold> BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; LDL, Low-Density Lipoprotein; TG, Triglyceride; 2hpp, Two-Hour Postprandial Glucose; FBS, Fasting Blood Sugar; HbA1c, Hemoglobin A1c.</p></fn></table-wrap-foot></table-wrap>
</p><p>In our study, genotypic frequency of SNPs variants was analyzed from the blood samples of 162 T2DM patients and 106 non-diabetic individuals from&#x000a0; the Iranian population. The genotypic frequencies of the homozygous (C/C), heterozygous (C/T), and homozygous (T/T) variants of the rs13266634 (T/C) significantly (P value&#x0003c;0.001) observed in 16 (9.88%), 64 (39.51%), and 82 (50.62%) of T2DM patients and 5 (4.72%), 23 (21.70%), and 78 (73.58. %) of the&#x000a0;control groups, respectively (<xref rid="T0003" ref-type="table">Table 3</xref>). Additionally, the&#x000a0;odd ratio of T2DM patients with C/T and C/C genotype was 2.64 and 3.04, respectively. However, patients with C/T (P=0.001) and C/C (P=0.038) genotypes significantly indicated high risk of T2DM in comparison with T/T genotype. The genotypic frequencies of homozygous (A/A), heterozygous (A/C), and homozygous (C/C) variants of the rs10946398 (A/C) significantly (P value&#x0003c;0.001) observed in 31 (19.14%), 104 (64.20%), and 27 (16.67%) of T2DM patients and 46 (43.40%), 50 (47.17%), and 10 (9.43%) of the&#x000a0;control groups. Additionally, the&#x000a0;odd ratio of T2DM patients with A/C and C/C genotypes were 3.08 and 4.0, respectively. However, patients with C/C and A/C genotypes significantly (P=0.001) indicated high risk of T2DM in comparison with A/A genotype (<xref rid="T0003" ref-type="table">Tables 3</xref> and <xref rid="T0004" ref-type="table">4</xref>).<table-wrap id="T0003" orientation="portrait" position="float"><label>Table 3</label><caption><p>The Genotypic Frequency of Polymorphisms Between T2DM and Control Groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="1">SNP</th><th rowspan="1" colspan="1">Control<break/>n (%)</th><th rowspan="1" colspan="1">T2DM<break/>n (%)</th><th rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">rs1470579 IGF2BP2</td><td rowspan="1" colspan="1">AA</td><td rowspan="1" colspan="1">55 (51.89%)</td><td rowspan="1" colspan="1">67 (41.36%)</td><td rowspan="3" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">11 (10.38%)</td><td rowspan="1" colspan="1">55 (33.95%)</td></tr><tr><td rowspan="1" colspan="1">AC</td><td rowspan="1" colspan="1">40 (37.74%)</td><td rowspan="1" colspan="1">40 (24.69%)</td></tr><tr><td rowspan="3" colspan="1">rs2237892 KCNQ1</td><td rowspan="1" colspan="1">TT</td><td rowspan="1" colspan="1">6 (5.66%)</td><td rowspan="1" colspan="1">1 (0.62%)</td><td rowspan="3" colspan="1">0.002*</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">85 (80.19%)</td><td rowspan="1" colspan="1">152 (93.83%)</td></tr><tr><td rowspan="1" colspan="1">CT</td><td rowspan="1" colspan="1">15 (14.15%)</td><td rowspan="1" colspan="1">9 (5.56%)</td></tr><tr><td rowspan="3" colspan="1">rs7903146 TCF7L2</td><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">51 (48.11%)</td><td rowspan="1" colspan="1">26 (16.05%)</td><td rowspan="3" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">CT</td><td rowspan="1" colspan="1">39 (36.79%)</td><td rowspan="1" colspan="1">76 (46.91%)</td></tr><tr><td rowspan="1" colspan="1">TT</td><td rowspan="1" colspan="1">16 (15.09%)</td><td rowspan="1" colspan="1">60 (37.04%)</td></tr><tr><td rowspan="3" colspan="1">rs8050136 FTO</td><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">25 (23.58%)</td><td rowspan="1" colspan="1">42 (25.93%)</td><td rowspan="3" colspan="1">0.132</td></tr><tr><td rowspan="1" colspan="1">AA</td><td rowspan="1" colspan="1">60 (56.60%)</td><td rowspan="1" colspan="1">73 (45.06%)</td></tr><tr><td rowspan="1" colspan="1">AC</td><td rowspan="1" colspan="1">21 (19.81%)</td><td rowspan="1" colspan="1">47 (29.01%)</td></tr><tr><td rowspan="3" colspan="1">rs10830963 MTNR1B</td><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">52 (49.06%)</td><td rowspan="1" colspan="1">58 (35.80%)</td><td rowspan="3" colspan="1">0.079</td></tr><tr><td rowspan="1" colspan="1">CG</td><td rowspan="1" colspan="1">44 (41.51%)</td><td rowspan="1" colspan="1">80 (49.38%)</td></tr><tr><td rowspan="1" colspan="1">GG</td><td rowspan="1" colspan="1">10 (9.43%)</td><td rowspan="1" colspan="1">24 (14.81%)</td></tr><tr><td rowspan="3" colspan="1">rs10946398 CDKAL1</td><td rowspan="1" colspan="1">AA</td><td rowspan="1" colspan="1">46 (43.40%)</td><td rowspan="1" colspan="1">31 (19.14%)</td><td rowspan="3" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">10 (9.43%)</td><td rowspan="1" colspan="1">27 (16.67%)</td></tr><tr><td rowspan="1" colspan="1">AC</td><td rowspan="1" colspan="1">50 (47.17%)</td><td rowspan="1" colspan="1">104 (64.20%)</td></tr><tr><td rowspan="3" colspan="1">rs13266634SLC30A8</td><td rowspan="1" colspan="1">TT</td><td rowspan="1" colspan="1">78 (73.58%)</td><td rowspan="1" colspan="1">82 (50.62%)</td><td rowspan="3" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">5 (4.72%)</td><td rowspan="1" colspan="1">16 (9.88%)</td></tr><tr><td rowspan="1" colspan="1">CT</td><td rowspan="1" colspan="1">23 (21.70%)</td><td rowspan="1" colspan="1">64 (39.51%)</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold> *statistically significant.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="T0004" orientation="portrait" position="float"><label>Table 4</label><caption><p>The Genotypic Frequency of Polymorphisms Between T2DM and Control Groups with Odds Ratio</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="1">SNP</th><th rowspan="1" colspan="1">Control<break/>n (%)</th><th rowspan="1" colspan="1">T2DM<break/>n (%)</th><th rowspan="1" colspan="1">Odds Ratio<sup>a</sup><break/>(95% CI)</th><th rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">rs1470579 IGF2BP2</td><td rowspan="1" colspan="1">AA</td><td rowspan="1" colspan="1">55 (51.89%)</td><td rowspan="1" colspan="1">67 (41.36%)</td><td rowspan="1" colspan="1">Ref.</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">11 (10.38%)</td><td rowspan="1" colspan="1">55 (33.95%)</td><td rowspan="1" colspan="1">4.1 (1.96&#x02013;8.59)</td><td rowspan="1" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">AC</td><td rowspan="1" colspan="1">40 (37.74%)</td><td rowspan="1" colspan="1">40 (24.69%)</td><td rowspan="1" colspan="1">0.82 (0.46&#x02013;1.44)</td><td rowspan="1" colspan="1">0.494</td></tr><tr><td rowspan="3" colspan="1">rs2237892 KCNQ1</td><td rowspan="1" colspan="1">TT</td><td rowspan="1" colspan="1">6 (5.66%)</td><td rowspan="1" colspan="1">1 (0.62%)</td><td rowspan="1" colspan="1">Ref.</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">85 (80.19%)</td><td rowspan="1" colspan="1">152 (93.83%)</td><td rowspan="1" colspan="1">10.79 (1.27&#x02013;90.6)</td><td rowspan="1" colspan="1">0.029*</td></tr><tr><td rowspan="1" colspan="1">CT</td><td rowspan="1" colspan="1">15 (14.15%)</td><td rowspan="1" colspan="1">9 (5.56%)</td><td rowspan="1" colspan="1">3.6 (0.37&#x02013;34.93)</td><td rowspan="1" colspan="1">0.269</td></tr><tr><td rowspan="3" colspan="1">rs7903146 TCF7L2</td><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">51 (48.11%)</td><td rowspan="1" colspan="1">26 (16.05%)</td><td rowspan="1" colspan="1">Ref.</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">CT</td><td rowspan="1" colspan="1">39 (36.79%)</td><td rowspan="1" colspan="1">76 (46.91%)</td><td rowspan="1" colspan="1">3.82 (2.07&#x02013;7.03)</td><td rowspan="1" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">TT</td><td rowspan="1" colspan="1">16 (15.09%)</td><td rowspan="1" colspan="1">60 (37.04%)</td><td rowspan="1" colspan="1">7.35 (3.55&#x02013;15.2)</td><td rowspan="1" colspan="1">0.001*</td></tr><tr><td rowspan="3" colspan="1">rs8050136 FTO</td><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">25 (23.58%)</td><td rowspan="1" colspan="1">42 (25.93%)</td><td rowspan="1" colspan="1">Ref.</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">AA</td><td rowspan="1" colspan="1">60 (56.60%)</td><td rowspan="1" colspan="1">73 (45.06%)</td><td rowspan="1" colspan="1">0.72 (0.39&#x02013;1.32)</td><td rowspan="1" colspan="1">0.293</td></tr><tr><td rowspan="1" colspan="1">AC</td><td rowspan="1" colspan="1">21 (19.81%)</td><td rowspan="1" colspan="1">47 (29.01%)</td><td rowspan="1" colspan="1">1.33 (0.65&#x02013;2.72)</td><td rowspan="1" colspan="1">0.431</td></tr><tr><td rowspan="3" colspan="1">rs10830963 MTNR1B</td><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">52 (49.06%)</td><td rowspan="1" colspan="1">58 (35.80%)</td><td rowspan="1" colspan="1">Ref.</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">CG</td><td rowspan="1" colspan="1">44 (41.51%)</td><td rowspan="1" colspan="1">80 (49.38%)</td><td rowspan="1" colspan="1">1.63 (0.96&#x02013;2.75)</td><td rowspan="1" colspan="1">0.068</td></tr><tr><td rowspan="1" colspan="1">GG</td><td rowspan="1" colspan="1">10 (9.43%)</td><td rowspan="1" colspan="1">24 (14.81%)</td><td rowspan="1" colspan="1">2.15 (0.94&#x02013;4.92)</td><td rowspan="1" colspan="1">0.069</td></tr><tr><td rowspan="3" colspan="1">rs10946398 CDKAL1</td><td rowspan="1" colspan="1">AA</td><td rowspan="1" colspan="1">46 (43.40%)</td><td rowspan="1" colspan="1">31 (19.14%)</td><td rowspan="1" colspan="1">Ref.</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">10 (9.43%)</td><td rowspan="1" colspan="1">27 (16.67%)</td><td rowspan="1" colspan="1">4.0 (1.70&#x02013;9.43)</td><td rowspan="1" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">AC</td><td rowspan="1" colspan="1">50 (47.17%)</td><td rowspan="1" colspan="1">104 (64.20%)</td><td rowspan="1" colspan="1">3.08 (1.75&#x02013;5.43)</td><td rowspan="1" colspan="1">0.001*</td></tr><tr><td rowspan="3" colspan="1">rs13266634 SLC30A8</td><td rowspan="1" colspan="1">TT</td><td rowspan="1" colspan="1">78 (73.58%)</td><td rowspan="1" colspan="1">82 (50.62%)</td><td rowspan="1" colspan="1">Ref.</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">CC</td><td rowspan="1" colspan="1">5 (4.72%)</td><td rowspan="1" colspan="1">16 (9.88%)</td><td rowspan="1" colspan="1">3.04 (1.06&#x02013;8.70)</td><td rowspan="1" colspan="1">0.038*</td></tr><tr><td rowspan="1" colspan="1">CT</td><td rowspan="1" colspan="1">23 (21.70%)</td><td rowspan="1" colspan="1">64 (39.51%)</td><td rowspan="1" colspan="1">2.64 (1.49&#x02013;4.67)</td><td rowspan="1" colspan="1">0.001*</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Notes:</bold>
<sup>a</sup>Crude odds ratio (95% CI); *statistically significant.</p></fn></table-wrap-foot></table-wrap>
</p><p>The genotypic frequencies of homozygous (C/C), heterozygous (C/T), and homozygous (T/T) variants of the rs7903146 (C/T) significantly (P value&#x0003c;0.001) observed in 26 (16.05%), 76 (46.91%), and 60 (37.04%) of T2DM patients and 51 (48.11%), 39 (36.79%), and 16 (15.09%) of control groups. Additionally, the&#x000a0;odd ratio of T2DM patients with T/T and C/T genotype were 7.35 and 3.82, respectively. However, patients with T/T and C/T genotypes (P=0.001) indicated high risk in comparison with C/C genotypes (<xref rid="T0003" ref-type="table">Tables 3</xref> and <xref rid="T0004" ref-type="table">4</xref>).</p><p>The genotypic frequencies of homozygous (A/A), heterozygous (A/C), and homozygous (C/C) variants of the rs1470579 (A/C) significantly (P value&#x0003c;0.001) observed in 67 (41.36%), 40 (24.69%), and 55 (33.95%) of T2DM patients and 55 (51.89%), 40 (37.74%), and 11 (10.38%) of the&#x000a0;control groups. Additionally, the&#x000a0;A/C genotype was evaluated using odd ratio (OR: 4.1) and it was significantly high&#x000a0;(P=0.001) in T2DM patients in comparison with A/A genotype (<xref rid="T0003" ref-type="table">Tables 3</xref> and <xref rid="T0004" ref-type="table">4</xref>). The genotypic frequencies of homozygous (T/T), heterozygous (C/T), and homozygous (C/C) variants of the rs2237892 (C/T) significantly (P value=0.002) observed in 1 (0.62%), 9 (5.56%), and 152 (93.83%) of T2DM patients and 6 (5.66%), 15 (14.15%), and 85 (80.19%) of the&#x000a0;control groups. Additionally, C/C genotype was evaluated using odd ratio (OR: 10.7) and it was significantly high&#x000a0;(P=0.029) in T2DM patients in comparison with the&#x000a0;T/T genotype (<xref rid="T0003" ref-type="table">Tables 3</xref> and <xref rid="T0004" ref-type="table">4</xref>). Additionally, there is no significant association of rs8050136 FTO (p value = 0.132) and rs10830963 MTNR1B (p value = 0.079) polymorphisms between T2DM patients and control groups (<xref rid="T0003" ref-type="table">Tables 3</xref> and <xref rid="T0004" ref-type="table">4</xref>).</p></sec><sec id="S0004"><title>Discussion</title><p>Type 2 diabetes mellitus (T2DM) is a complicated multi-gene or polygenic disorder involved with unknown contributing genes that increase the risk of T2DM in susceptible individuals. Recently, 16 novel susceptible gene loci for T2DM were identified,<xref rid="CIT0044" ref-type="bibr">44</xref> but the impact of TCF7L2 is much higher in comparison with other confirmed T2D gene candidate.<xref rid="CIT0045" ref-type="bibr">45</xref></p><p>The interaction of multiple genes and genetic and environmental factors lead to hyperglycemia due to impaired insulin function or secretion. Therefore, different strategies have been attempted to identify involved genes with T2DM. However, investigation in different ethnicities and geographical region demonstrated different results across the world. SNPs in SLC30A8 (rs13266634), <italic>CDKAL1</italic> rs10946398, TCF7L2 rs7903146, KCNQ1 rs2237892, IGF2BP2 rs1470579 and MTNR1B rs10830963 were reported to be associated with T2DM in different studies.<xref rid="CIT0046" ref-type="bibr">46</xref>&#x02013;<xref rid="CIT0049" ref-type="bibr">49</xref> Our study demonstrated that <italic>SLC30A8</italic> rs13266634 (T/C), <italic>CDKAL1</italic> rs10946398 (A/C), TCF7L2 rs7903146 (C/T),KCNQ1 rs2237892 (T/C), and IGF2BP2 rs1470579 (A/C) polymorphisms are significantly in association with type 2 diabetes, but no significant association was identified for FTO rs8050136 and MTNR1B rs10830963 polymorphisms in present study.</p><p>Of 31 provinces in Iran, studies on only two provinces, Gorgan<xref rid="CIT0050" ref-type="bibr">50</xref> and Kurdish,<xref rid="CIT0051" ref-type="bibr">51</xref> revealed that the frequency of the TCF7L2 rs7903146 polymorphism was significant, which is in agreement with present study. In contrast to our study, a lack of remarkable association between TCF7L2 rs7903146 polymorphism and T2D was reported among&#x000a0;the Arabian Emirates<xref rid="CIT0052" ref-type="bibr">52</xref> and Saudi Arab population.<xref rid="CIT0053" ref-type="bibr">53</xref> Here, the association of various SNPs with T2DM risk was investigated among Iranian individuals. However, the limitation of our study was to demonstrate the association of mortality and clinical complications with T2DM. The fundamental mechanisms, by which genetic variations within the intron of the TCF7L2 gene confers susceptibility to T2DM, remain to be elucidated. However, a study indicated that genetic variations around 3&#x002b9;end of the TCF&#x00026;L2 gene may affect the function of TCF7L2, due to regulation of alternative splicing.<xref rid="CIT0054" ref-type="bibr">54</xref> The lack of statistically significant differences in the allelic and genotypic frequencies of FTO rs8050136 and MTNR1B rs10830963 polymorphisms between T2DM and control groups may be partially interpreted due to the&#x000a0;heterogeneity of the individual&#x02019;s ethnicity. It is accepted that approximately 14% of the between-studies variances may be attributed to ethnicity differences.<xref rid="CIT0055" ref-type="bibr">55</xref></p></sec><sec id="S0005"><title>Conclusion</title><p>In conclusion, our study indicated the association of well-established common variants of <italic>SLC30A8</italic> rs13266634 (T/C), <italic>CDKAL1</italic> rs10946398 (A/C), TCF7L2 rs7903146 (C/T), KCNQ1 rs2237892 (T/C), and IGF2BP2 rs1470579 (A/C) with type 2 diabetes among Iranian population from Tehran. Our study indicated the remarkable presence of the rs13266634, 10946398, 7903146, 2237892 and 1470579 polymorphisms in Iranian population, suggesting susceptibility of individuals to T2DM which may lead to identification of individuals with high risk for developing T2DM. Additionally, this study demonstrated the absence of the&#x000a0;common variant FTO rs8050136 (C/A) among Iranian population. It is clinically important to manifest individuals for pharmacogenetics and pharmacogenomics approaches and prevention of harmful complication of this silent disease and adverse drug reactions. Therefore, identification of involved polymorphism analysis improves individual lifestyle and is a helpful tool toward personalized medicine and avoidance of the harmful effects of drugs.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to appreciate the Shahid Sadoughi University of Medical Sciences and Health Services for providing facilities and financial supports to this study. They also thank Taban Health Care and Diabetes Clinic and Aramesh Genetic and Pathobiology Lab for providing facilities for registration and collection of consent form from diabetic patients and non-diabetic individuals and supporting the laboratory technical equipment. The present article was adopted from research proposal No. 4897 approved by the Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran.</p></ack><sec id="S0006"><title>Author Contributions</title><p>Conceived the experiments: Seyed Mehdi Kalantar, Massoud Houshmand and Kazem Vatankhah Yazdi; Designed the experiments: Masoud Reza Manaviat and Masoud Rahmanian; Collection of specimens and consent form: Kazem Vatankhah Yazdi, Mohammad Reza Jahani; Performed the experiments: Kazem Vatankhah Yazdi; Analyzed the data: Amir Almasi-Hashiani; Contributed reagents/materials/analysis tools: Kazem Vatankhah Yazdi, Seyed Mehdi Kalantar and Massoud Houshmand; Wrote the paper: Kazem Vatankhah Yazdi and Behnam Kamalidehghan; Revised and approved the manuscript: Kazem Vatankhah Yazdi and Behnam Kamalidehghan. All authors contributed to data analysis, drafting or revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.</p></sec><sec id="S0007" sec-type="COI-statement"><title>Disclosure</title><p>The authors report no conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Nyenwe</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Jerkins</surname>
<given-names>TW</given-names></string-name>, <string-name><surname>Umpierrez</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Kitabchi</surname>
<given-names>AE</given-names></string-name>. <article-title>Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes</article-title>. <source><italic toggle="yes">Metabolism</italic></source>. <year>2011</year>;<volume>60</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.metabol.2010.09.010</pub-id><pub-id pub-id-type="pmid">21134520</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Horikawa</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Oda</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Cox</surname>
<given-names>NJ</given-names></string-name>, et al. <article-title>Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2000</year>;<volume>26</volume>(<issue>2</issue>):<fpage>163</fpage>. doi:<pub-id pub-id-type="doi">10.1038/79876</pub-id><pub-id pub-id-type="pmid">11017071</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Hu</surname>
<given-names>FB</given-names></string-name>. <article-title>Globalization of diabetes: the role of diet, lifestyle, and genes</article-title>. <source><italic toggle="yes">Diabetes Care</italic></source>. <year>2011</year>;<volume>34</volume>(<issue>6</issue>):<fpage>1249</fpage>&#x02013;<lpage>1257</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dc11-0442</pub-id><pub-id pub-id-type="pmid">21617109</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Timper</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Donath</surname>
<given-names>MY</given-names></string-name>. <article-title>Diabetes mellitus type 2-the new face of an old lady</article-title>. <source><italic toggle="yes">Swiss Med Wkly</italic></source>. <year>2012</year>;<volume>142</volume>:<fpage>2930</fpage>.</mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Esteghamati</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gouya</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Abbasi</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran</article-title>. <source><italic toggle="yes">Diabetes Care</italic></source>. <year>2008</year>;<volume>31</volume>(<issue>1</issue>):<fpage>96</fpage>&#x02013;<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dc07-0959</pub-id><pub-id pub-id-type="pmid">17921357</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Ridderstr&#x000e5;le</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Groop</surname>
<given-names>L</given-names></string-name>. <article-title>Genetic dissection of type 2 diabetes</article-title>. <source><italic toggle="yes">Mol Cell Endocrinol</italic></source>. <year>2009</year>;<volume>297</volume>(<issue>1&#x02013;2</issue>):<fpage>10</fpage>&#x02013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mce.2008.10.002</pub-id><pub-id pub-id-type="pmid">19000735</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Gloyn</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>MI</given-names></string-name>. <article-title>The genetics of type 2 diabetes</article-title>. <source><italic toggle="yes">Best Pract Res Clin Endocrinol Metab</italic></source>. <year>2001</year>;<volume>15</volume>(<issue>3</issue>):<fpage>293</fpage>&#x02013;<lpage>308</lpage>. doi:<pub-id pub-id-type="doi">10.1053/beem.2001.0147</pub-id><pub-id pub-id-type="pmid">11554772</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Christiansen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kolte</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>FC</given-names></string-name>. <article-title>IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes</article-title>. <source><italic toggle="yes">J Mol Endocrinol</italic></source>. <year>2009</year>;<volume>43</volume>(<issue>5</issue>):<fpage>187</fpage>&#x02013;<lpage>195</lpage>. doi:<pub-id pub-id-type="doi">10.1677/JME-09-0016</pub-id><pub-id pub-id-type="pmid">19429674</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Zeggini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Weedon</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Lindgren</surname>
<given-names>CM</given-names></string-name>, et al. <article-title>Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2007</year>;<volume>316</volume>(<issue>5829</issue>):<fpage>1336</fpage>&#x02013;<lpage>1341</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1142364</pub-id><pub-id pub-id-type="pmid">17463249</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Nielsen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Christiansen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lykke-andersen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Johnsen</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Wewer</surname>
<given-names>UM</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>FC</given-names></string-name>. <article-title>A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development</article-title>. <source><italic toggle="yes">Mol Cell Biol</italic></source>. <year>1999</year>;<volume>19</volume>(<issue>2</issue>):<fpage>1262</fpage>&#x02013;<lpage>1270</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MCB.19.2.1262</pub-id><pub-id pub-id-type="pmid">9891060</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Ullrich</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ranta</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Effects of I Ks channel inhibitors in insulin-secreting INS-1 cells</article-title>. <source><italic toggle="yes">Pflugers Arch</italic></source>. <year>2005</year>;<volume>451</volume>(<issue>3</issue>):<fpage>428</fpage>&#x02013;<lpage>436</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00424-005-1479-2</pub-id><pub-id pub-id-type="pmid">16133261</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Barhanin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lesage</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Guillemare</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Fink</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lazdunski</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Romey</surname>
<given-names>G</given-names></string-name>. <article-title>K V LQT1 and IsK (minK) proteins associate to form the I Ks cardiac potassium current</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>1996</year>;<volume>384</volume>(<issue>6604</issue>):<fpage>78</fpage>. doi:<pub-id pub-id-type="doi">10.1038/384078a0</pub-id><pub-id pub-id-type="pmid">8900282</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Neyroud</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tesson</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Denjoy</surname>
<given-names>I</given-names></string-name>, et al. <article-title>A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>1997</year>;<volume>15</volume>(<issue>2</issue>):<fpage>186</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ng0297-186</pub-id><pub-id pub-id-type="pmid">9020846</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Larsen</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Fosdal</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>PS</given-names></string-name>, et al. <article-title>Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene</article-title>. <source><italic toggle="yes">Eur J Hum Genet</italic></source>. <year>1999</year>;<volume>7</volume>(<issue>6</issue>):<fpage>724</fpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.ejhg.5200323</pub-id><pub-id pub-id-type="pmid">10482963</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>S-Y</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>J</given-names></string-name>, et al. <article-title>TCF7L2 is a master regulator of insulin production and processing</article-title>. <source><italic toggle="yes">Hum Mol Genet</italic></source>. <year>2014</year>;<volume>23</volume>(<issue>24</issue>):<fpage>6419</fpage>&#x02013;<lpage>6431</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddu359</pub-id><pub-id pub-id-type="pmid">25015099</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Elbein</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Das</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent</article-title>. <source><italic toggle="yes">Diabetologia</italic></source>. <year>2007</year>;<volume>50</volume>(<issue>8</issue>):<fpage>1621</fpage>&#x02013;<lpage>1630</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00125-007-0717-x</pub-id><pub-id pub-id-type="pmid">17579832</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>McCarthy</surname>
<given-names>MI</given-names></string-name>. <article-title>Genomics, type 2 diabetes, and obesity</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2010</year>;<volume>363</volume>(<issue>24</issue>):<fpage>2339</fpage>&#x02013;<lpage>2350</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMra0906948</pub-id><pub-id pub-id-type="pmid">21142536</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Lindgren</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Heid</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Randall</surname>
<given-names>JC</given-names></string-name>, et al. <article-title>Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution</article-title>. <source><italic toggle="yes">PLoS Genet</italic></source>. <year>2009</year>;<volume>5</volume>(<issue>6</issue>):<fpage>e1000508</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1000508</pub-id><pub-id pub-id-type="pmid">19557161</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Hotta</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kitamoto</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kitamoto</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population</article-title>. <source><italic toggle="yes">J Hum Genet</italic></source>. <year>2011</year>;<volume>56</volume>(<issue>9</issue>):<fpage>647</fpage>. doi:<pub-id pub-id-type="doi">10.1038/jhg.2011.74</pub-id><pub-id pub-id-type="pmid">21796137</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Chauhan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tabassum</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mahajan</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Common variants of FTO and the risk of obesity and type 2 diabetes in Indians</article-title>. <source><italic toggle="yes">J Hum Genet</italic></source>. <year>2011</year>;<volume>56</volume>(<issue>10</issue>):<fpage>720</fpage>. doi:<pub-id pub-id-type="doi">10.1038/jhg.2011.87</pub-id><pub-id pub-id-type="pmid">21814223</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Peng</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>M</given-names></string-name>. <article-title>FTO gene polymorphisms and obesity risk: a meta-analysis</article-title>. <source><italic toggle="yes">BMC Med</italic></source>. <year>2011</year>;<volume>9</volume>(<issue>1</issue>):<fpage>71</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1741-7015-9-71</pub-id><pub-id pub-id-type="pmid">21651756</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>Y-C</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>P-H</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>Y-H</given-names></string-name>, et al. <article-title>Validation of type 2 diabetes risk variants identified by genome-wide association studies in Han Chinese population: a replication study and meta-analysis</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2014</year>;<volume>9</volume>(<issue>4</issue>):<fpage>e95045</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0095045</pub-id><pub-id pub-id-type="pmid">24736664</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Xiao</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Quan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>J</given-names></string-name>. <article-title>Correlation between polymorphism of FTO gene and type 2 diabetes mellitus in Uygur people from northwest China</article-title>. <source><italic toggle="yes">Int J Clin Exp Med</italic></source>. <year>2015</year>;<volume>8</volume>(<issue>6</issue>):<fpage>9744</fpage>.<pub-id pub-id-type="pmid">26309651</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Loos</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Yeo</surname>
<given-names>GS</given-names></string-name>. <article-title>The bigger picture of FTO&#x02014;the first GWAS-identified obesity gene</article-title>. <source><italic toggle="yes">Nat Rev Endocrinol</italic></source>. <year>2014</year>;<volume>10</volume>(<issue>1</issue>):<fpage>51</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nrendo.2013.227</pub-id><pub-id pub-id-type="pmid">24247219</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Chambers</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Elliott</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Zabaneh</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Common genetic variation near MC4R is associated with waist circumference and insulin resistance</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2008</year>;<volume>40</volume>(<issue>6</issue>):<fpage>716</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.156</pub-id><pub-id pub-id-type="pmid">18454146</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Meyre</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Delplanque</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ch&#x000e8;vre</surname>
<given-names>J-C</given-names></string-name>, et al. <article-title>Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2009</year>;<volume>41</volume>(<issue>2</issue>):<fpage>157</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.301</pub-id><pub-id pub-id-type="pmid">19151714</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Lyssenko</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Nagorny</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Erdos</surname>
<given-names>MR</given-names></string-name>, et al. <article-title>Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2009</year>;<volume>41</volume>(<issue>1</issue>):<fpage>82</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.288</pub-id><pub-id pub-id-type="pmid">19060908</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Bouatia-naji</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bonnefond</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cavalcanti-proen&#x000e7;a</surname>
<given-names>C</given-names></string-name>, et al. <article-title>A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2009</year>;<volume>41</volume>(<issue>1</issue>):<fpage>89</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.277</pub-id><pub-id pub-id-type="pmid">19060909</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Patel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rathwa</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Palit</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Ramachandran</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Begum</surname>
<given-names>R</given-names></string-name>. <article-title>Association of melatonin &#x00026; MTNR1B variants with type 2 diabetes in Gujarat population</article-title>. <source><italic toggle="yes">Biomed Pharmacother</italic></source>. <year>2018</year>;<volume>103</volume>:<fpage>429</fpage>&#x02013;<lpage>434</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopha.2018.04.058</pub-id><pub-id pub-id-type="pmid">29674279</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Karamitri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jockers</surname>
<given-names>R</given-names></string-name>. <article-title>Melatonin in type 2 diabetes mellitus and obesity</article-title>. <source><italic toggle="yes">Nat Rev Endocrinol</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>2</issue>):<fpage>105</fpage>&#x02013;<lpage>125</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41574-018-0130-1</pub-id><pub-id pub-id-type="pmid">30531911</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Sladek</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rocheleau</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Rung</surname>
<given-names>J</given-names></string-name>, et al. <article-title>A genome-wide association study identifies novel risk loci for type 2 diabetes</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2007</year>;<volume>445</volume>(<issue>7130</issue>):<fpage>881</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nature05616</pub-id><pub-id pub-id-type="pmid">17293876</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Cauchi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Del Guerra</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Choquet</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets</article-title>. <source><italic toggle="yes">Mol Genet Metab</italic></source>. <year>2010</year>;<volume>100</volume>(<issue>1</issue>):<fpage>77</fpage>&#x02013;<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ymgme.2010.01.001</pub-id><pub-id pub-id-type="pmid">20138556</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>El Dib</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gameiro</surname>
<given-names>OL</given-names></string-name>, <string-name><surname>Ogata</surname>
<given-names>MS</given-names></string-name>, et al. <article-title>Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2015</year>;<volume>5</volume>:<fpage>CD005525</fpage>.</mixed-citation></ref><ref id="CIT0034"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Shan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Bao</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes</article-title>. <source><italic toggle="yes">Diabetes</italic></source>. <year>2014</year>;<volume>63</volume>(<issue>5</issue>):<fpage>1796</fpage>&#x02013;<lpage>1803</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db13-0606</pub-id><pub-id pub-id-type="pmid">24306209</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Steinthorsdottir</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Thorleifsson</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Reynisdottir</surname>
<given-names>I</given-names></string-name>, et al. <article-title>A variant in CDKAL1 influences insulin response and risk of type 2 diabetes</article-title>. <source><italic toggle="yes">Nat Genet</italic></source>. <year>2007</year>;<volume>39</volume>(<issue>6</issue>):<fpage>770</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ng2043</pub-id><pub-id pub-id-type="pmid">17460697</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Pierrel</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Douki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Fontecave</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Atta</surname>
<given-names>M</given-names></string-name>. <article-title>MiaB protein is a bifunctional radical-S-adenosylmethionine enzyme involved in thiolation and methylation of tRNA</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2004</year>;<volume>279</volume>(<issue>46</issue>):<fpage>47555</fpage>&#x02013;<lpage>47563</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M408562200</pub-id><pub-id pub-id-type="pmid">15339930</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Wei</surname>
<given-names>F-Y</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Deficit of tRNA Lys modification by Cdkal1 causes the development of type 2 diabetes in mice</article-title>. <source><italic toggle="yes">J Clin Invest</italic></source>. <year>2011</year>;<volume>121</volume>:<fpage>9</fpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI58056</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>YS</given-names></string-name>, et al. <article-title>A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients</article-title>. <source><italic toggle="yes">Diabetes</italic></source>. <year>2008</year>;<volume>57</volume>(<issue>4</issue>):<fpage>1043</fpage>&#x02013;<lpage>1047</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db07-0761</pub-id><pub-id pub-id-type="pmid">18162509</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Rutter</surname>
<given-names>GA</given-names></string-name>. <article-title>Think zinc: new roles for zinc in the control of insulin secretion</article-title>. <source><italic toggle="yes">Islets</italic></source>. <year>2010</year>;<volume>2</volume>(<issue>1</issue>):<fpage>49</fpage>&#x02013;<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.4161/isl.2.1.10259</pub-id><pub-id pub-id-type="pmid">21099294</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Xiang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X-Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2008</year>;<volume>93</volume>(<issue>10</issue>):<fpage>4107</fpage>&#x02013;<lpage>4112</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2008-0161</pub-id><pub-id pub-id-type="pmid">18628523</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Chimienti</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Favier</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Seve</surname>
<given-names>M</given-names></string-name>. <article-title>ZnT-8, a pancreatic beta-cell-specific zinc transporter</article-title>. <source><italic toggle="yes">Biometals</italic></source>. <year>2005</year>;<volume>18</volume>(<issue>4</issue>):<fpage>313</fpage>&#x02013;<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10534-005-3687-9</pub-id><pub-id pub-id-type="pmid">16158222</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Scott</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Mohlke</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Bonnycastle</surname>
<given-names>LL</given-names></string-name>, et al. <article-title>A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants</article-title>. <source><italic toggle="yes">science</italic></source>. <year>2007</year>;<volume>316</volume>(<issue>5829</issue>):<fpage>1341</fpage>&#x02013;<lpage>1345</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1142382</pub-id><pub-id pub-id-type="pmid">17463248</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Saxena</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Voight</surname>
<given-names>BF</given-names></string-name>, <string-name><surname>Lyssenko</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2007</year>;<volume>316</volume>(<issue>5829</issue>):<fpage>1331</fpage>&#x02013;<lpage>1336</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1142358</pub-id><pub-id pub-id-type="pmid">17463246</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Spars&#x000f8;</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Grarup</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Andreasen</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene&#x02013;gene interaction</article-title>. <source><italic toggle="yes">Diabetologia</italic></source>. <year>2009</year>;<volume>52</volume>(<issue>7</issue>):<fpage>1308</fpage>&#x02013;<lpage>1314</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00125-009-1362-3</pub-id><pub-id pub-id-type="pmid">19404609</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Cauchi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>El Achhab</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Choquet</surname>
<given-names>H</given-names></string-name>, et al. <article-title>TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis</article-title>. <source><italic toggle="yes">J Mol Med</italic></source>. <year>2007</year>;<volume>85</volume>(<issue>7</issue>):<fpage>777</fpage>&#x02013;<lpage>782</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00109-007-0203-4</pub-id><pub-id pub-id-type="pmid">17476472</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zha</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes&#x02014;a meta-analysis</article-title>. <source><italic toggle="yes">Diabetes Res Clin Pract</italic></source>. <year>2011</year>;<volume>91</volume>(<issue>2</issue>):<fpage>195</fpage>&#x02013;<lpage>202</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.diabres.2010.11.012</pub-id><pub-id pub-id-type="pmid">21131091</pub-id></mixed-citation></ref><ref id="CIT0047"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Jing</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Bi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>D</given-names></string-name>. <article-title>SLC30A8 polymorphism and type 2 diabetes risk: evidence from 27 study groups</article-title>. <source><italic toggle="yes">Nutr Metab Cardiovasc Dis</italic></source>. <year>2011</year>;<volume>21</volume>(<issue>6</issue>):<fpage>398</fpage>&#x02013;<lpage>405</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.numecd.2009.11.004</pub-id><pub-id pub-id-type="pmid">20167458</pub-id></mixed-citation></ref><ref id="CIT0048"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Chauhan</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Spurgeon</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Tabassum</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5164 Indians</article-title>. <source><italic toggle="yes">Diabetes</italic></source>. <year>2010</year>;<volume>59</volume>(<issue>8</issue>):<fpage>2068</fpage>&#x02013;<lpage>2074</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db09-1386</pub-id><pub-id pub-id-type="pmid">20424228</pub-id></mixed-citation></ref><ref id="CIT0049"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Han</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>Q</given-names></string-name>, et al. <article-title>Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population</article-title>. <source><italic toggle="yes">BMC Med Genet</italic></source>. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>81</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2350-11-81</pub-id><pub-id pub-id-type="pmid">20509872</pub-id></mixed-citation></ref><ref id="CIT0050"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Alami</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Ahmadi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bazrafshan</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Association of the TCF7L2 rs12255372 (G/T) variant with type 2 diabetes mellitus in an Iranian population</article-title>. <source><italic toggle="yes">Genet Mol Biol</italic></source>. <year>2012</year>;<volume>35</volume>(<issue>2</issue>):<fpage>413</fpage>&#x02013;<lpage>417</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S1415-47572012005000029</pub-id><pub-id pub-id-type="pmid">22888288</pub-id></mixed-citation></ref><ref id="CIT0051"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Shokouhi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Delpisheh</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Haghani</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Mahdizadeh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bakhtiyari</surname>
<given-names>S</given-names></string-name>. <article-title>Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group</article-title>. <source><italic toggle="yes">Clin Lab</italic></source>. <year>2014</year>;<volume>60</volume>(<issue>8</issue>):<fpage>1269</fpage>&#x02013;<lpage>1276</lpage>. doi:<pub-id pub-id-type="doi">10.7754/Clin.Lab.2013.130809</pub-id><pub-id pub-id-type="pmid">25185411</pub-id></mixed-citation></ref><ref id="CIT0052"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Saadi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Nagelkerke</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Carruthers</surname>
<given-names>SG</given-names></string-name>, et al. <article-title>Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects</article-title>. <source><italic toggle="yes">Diabetes Res Clin Pract</italic></source>. <year>2008</year>;<volume>80</volume>(<issue>3</issue>):<fpage>392</fpage>&#x02013;<lpage>398</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.diabres.2008.01.008</pub-id><pub-id pub-id-type="pmid">18282631</pub-id></mixed-citation></ref><ref id="CIT0053"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Alsmadi</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Al-rubeaan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Mohamed</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population</article-title>. <source><italic toggle="yes">BMC Med Genet</italic></source>. <year>2008</year>;<volume>9</volume>(<issue>1</issue>):<fpage>72</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2350-9-72</pub-id><pub-id pub-id-type="pmid">18655717</pub-id></mixed-citation></ref><ref id="CIT0054"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>Y-C</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>T-J</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>Y-D</given-names></string-name>, et al. <article-title>Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population</article-title>. <source><italic toggle="yes">Diabetes</italic></source>. <year>2007</year>;<volume>56</volume>(<issue>10</issue>):<fpage>2631</fpage>&#x02013;<lpage>2637</lpage>. doi:<pub-id pub-id-type="doi">10.2337/db07-0421</pub-id><pub-id pub-id-type="pmid">17579206</pub-id></mixed-citation></ref><ref id="CIT0055"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Yen</surname>
<given-names>C-J</given-names></string-name>, <string-name><surname>Beamer</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Negri</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Molecular scanning of the human peroxisome proliferator activated receptor &#x003b3; (hPPAR&#x003b3;) gene in diabetic Caucasians: identification of a Pro12Ala PPAR&#x003b3;2 missense mutation</article-title>. <source><italic toggle="yes">Biochem Biophys Res Commun</italic></source>. <year>1997</year>;<volume>241</volume>(<issue>2</issue>):<fpage>270</fpage>&#x02013;<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1006/bbrc.1997.7798</pub-id><pub-id pub-id-type="pmid">9425261</pub-id></mixed-citation></ref></ref-list></back></article>